Approach of Turkish ophthalmologists to micronutrition in age-related macular degeneration

dc.contributor.authorSahin, Muhammed
dc.contributor.authorYuksel, Harun
dc.contributor.authorSahin, Alparslan
dc.contributor.authorCingu, Abdullah Kursat
dc.contributor.authorTurkcu, Fatih Mehmet
dc.contributor.authorOzkurt, Zeynep Gursel
dc.contributor.authorCaca, Ihsan
dc.date.accessioned2024-04-24T17:28:10Z
dc.date.available2024-04-24T17:28:10Z
dc.date.issued2015
dc.departmentDicle Üniversitesien_US
dc.description.abstractPurpose: To evaluate the knowledge and behaviors of ophthalmologists in Turkey concerning micronutrition support in patients with age related macular degeneration (ARMD). Methods: This study involved 1,845 ophthalmologists. A scientific poll was sent to all participants by email. The survey covered the following: demographic features, subspecialty knowledge about micronutrition preference for prescribing micronutrition to age related macular degeneration patients, and the reason for this preference. If a participant indicated that he or she prescribed micronutrition, the participant was also asked to indicate the source of the treatment and supplemental treatments. Results: Of 1,845 ophthalmologists, 249 responded to the survey. Of the respondents, 9% (22) never, 43% (107) sometimes, 37% (92) frequently, and 11% (27) always used micronutrition. The most frequent prescribing subgroup was general ophthalmology (22%), followed by the retina-uvea subspecialty (13.9%). The micronutrition prescribing ratio was 54.8% in retina-uvea specialists when the frequent and always responses were combined. There was no statistically significant difference between subgroups with respect to prescribing micronutrition. Among the ophthalmologists prescribing micronutrition, 57.1% of them did not use the Age-Related Eye Disease Study-1 (AREDS) criteria, and only 31.3% prescribe micronutrition according to AREDS criteria. The results for the general ophthalmologist and retina-uvea specialist subgroups were similar, 56.3% vs 20.2%, and 54.1% vs 36.1%, respectively. Micronutrition was not recommended for the following reasons: expensive (55.4%), low patient expectancy (40%), no effect (30%), and low patient drug compliance (25.4%). Moreover, 55.2% of the clinicians recommended physical activities, dietary changes, and smoking cessation; 7.3% did not recommend these behavioral changes. Conclusion: This survey demonstrated that micronutrition preference in age related macular degeneration was low in ophthalmologists in Turkey. Additionally, retina specialists have a lower rate of prescribing micronutrition. Micronutrition support and behavior such as smoking cessation, dietary changes, etc. should be recommended more often to patients with age related macular degeneration.en_US
dc.identifier.doi10.5935/0004-2749.20150004
dc.identifier.endpage14en_US
dc.identifier.issn0004-2749
dc.identifier.issn1678-2925
dc.identifier.issue1en_US
dc.identifier.pmid25714530
dc.identifier.scopus2-s2.0-84923453271
dc.identifier.scopusqualityQ3
dc.identifier.startpage10en_US
dc.identifier.urihttps://doi.org/10.5935/0004-2749.20150004
dc.identifier.urihttps://hdl.handle.net/11468/20352
dc.identifier.volume78en_US
dc.identifier.wosWOS:000350332900004
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherConsel Brasil Oftalmologiaen_US
dc.relation.ispartofArquivos Brasileiros De Oftalmologia
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectMacular Degeneration/Prevention & Controlen_US
dc.subjectDietary Supplementsen_US
dc.subjectVi-Tamins/Administration & Dosageen_US
dc.subjectLutein/Administration & Dosageen_US
dc.subjectGuideline As Topic/Standardsen_US
dc.subjectTurkeyen_US
dc.titleApproach of Turkish ophthalmologists to micronutrition in age-related macular degenerationen_US
dc.titleApproach of Turkish ophthalmologists to micronutrition in age-related macular degeneration
dc.typeArticleen_US

Dosyalar